Futures and Options Serving Intelligent Investors
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segment Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc.
Tags analysis PAREXEL International Corporation PRXL Research
Related Articles
Check Also
Facebook news and analysis
Facebook reported better than expected 1Q results after the bell. FB reported earnings of $3.30/share topping the expectations of $2.37/share